In a landmark move, the Supreme Court of India refused to block Natco Pharma from producing a low-cost version of Roche’s SMA drug, Evrysdi, marking a powerful stand for affordable healthcare. The Roche-Natco SMA drug patent dispute underscores India’s constitutional commitment to prioritize life over profit, reaffirming its legacy as the world’s pharmacy.

India’s proposed Trade Secrets Bill aims to safeguard confidential business information — a long-missing layer of protection for startups, innovators, and investors. By defining what qualifies as a trade secret and setting penalties for misuse, the law could reshape how companies secure their know-how and gain investor confidence in India’s growing innovation ecosystem.